# CJC-1295 + ipamorelin + tesamorelin blend

Source: https://aminodesk.com/library/cjc-1295-ipamorelin-tesamorelin
Publisher: Amino Desk
Updated: 2026-11-17
Clinical review: pending

This blend puts CJC-1295, ipamorelin and tesamorelin in one vial. It is sold for growth hormone support, fat loss and recovery. No trial has tested the combination in people, and two of the three ingredients cannot be legally compounded.

- **Legal lane:** not FDA-approved as a blend. CJC-1295 and ipamorelin are not eligible for pharmacy compounding.
- **Evidence grade:** D for the combination
- **What is in it:** CJC-1295, ipamorelin and tesamorelin
- **Established human dose:** none

## What it is

A premixed vial sold by peptide suppliers and some clinics. The ingredients:

- **[CJC-1295](https://aminodesk.com/library/cjc-1295):** not approved and not eligible for compounding; its human evidence is a 2006 hormone study.
- **[ipamorelin](https://aminodesk.com/library/ipamorelin):** not approved; an FDA advisory committee voted 0 to 12 against allowing it to be compounded.
- **[tesamorelin](https://aminodesk.com/library/tesamorelin):** FDA-approved as Egrifta, only to reduce excess abdominal fat in people with HIV and lipodystrophy.

All three push the pituitary to release growth hormone. CJC-1295 and tesamorelin work through the same receptor, so the blend partly doubles up on one signal.

## What the evidence shows

There is no trial of this blend. The evidence that exists applies to each ingredient studied on its own, and each ingredient's page has its grade and what was shown.

The case for mixing them is that they act by different routes, so the effects should add up. That is a hypothesis. Nobody has measured whether the mixture does better than its parts, or whether it is as safe.

## Legal status

- **CJC-1295:** not approved, and not on the list of substances pharmacies may compound. An FDA advisory committee recommended against adding it.
- **Ipamorelin:** not approved, and an FDA advisory committee voted 0 to 12, with one abstention, against allowing it to be compounded.
- **Tesamorelin:** a prescription drug approved for one use.
- No approved product and no compounding route stands behind a vial of all three.

## Reported dosing

**No dose has been established for this blend.**

No human trial has tested it. The mixing tables and schedules published by sellers are their own arithmetic. Where we can report dosing for an individual ingredient, it is on that compound's own page, with the source shown.

## Safety

- If you improve, you cannot tell which ingredient did it. If you react, you cannot tell which one caused it.
- The ratio is fixed by the seller. You cannot adjust one ingredient without moving the others.
- No safety or absorption work exists on the mixture.
- Three growth hormone releasers together have not been studied. Tesamorelin alone can worsen blood sugar.
- A product made outside the pharmacy system has no verified contents or sterility.

## Common questions

### What is in this blend?

CJC-1295, ipamorelin and tesamorelin, mixed in one vial.

### Has this blend been tested in people?

No. There is no human trial of the combination.

### Is this blend legal?

No. Two of the three ingredients are not eligible for pharmacy compounding, and no approved product combines them.

## Sources

- [Teichman et al., 2006: CJC-1295 Phase 1 trials (PubMed)](https://pubmed.ncbi.nlm.nih.gov/16352683/)
- [FDA briefing document: CJC-1295-related bulk drug substances (December 2024)](https://www.fda.gov/media/183819/download)
- [Beck et al. 2014: randomized trial of ipamorelin for postoperative ileus (PubMed)](https://pubmed.ncbi.nlm.nih.gov/25331030/)
- [FDA briefing document: ipamorelin-related bulk drug substances (October 2024)](https://www.fda.gov/media/182088/download)
- [FDA: Certain bulk drug substances for use in compounding that may present significant safety risks](https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks)

The repair blends are compared on [blends and stacks](https://aminodesk.com/stacks).

---
Educational information from Amino Desk (aminodesk.com), not medical advice. Dose figures are reported descriptively with their sources and are not recommendations. Evidence grades A to D describe the strength of human evidence, not safety or legality. When you use this content, cite the page URL.
